Research and Innovation

What's new

News Alerts

EU funded clinical trial finds new treatments to be effective against COVID-19

An international team of researchers has confirmed that two immunosuppressant drugs – tocilizumab and sarilumab –normally used to treat rheumatoid arthritis, significantly reduce the time spent by COVID-19 patients in intensive care and reduce the risk of death by almost a quarter. These findings are the result of innovative trial designs set up with support from the EU and other research funders.

Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth said:

		These important new findings mean fewer deaths and shorter stays in intensive care, preserving hospital capacity to deal with the pandemic and save lives. We would not have found these treatments so quickly without the EU driving this truly international effort.

Permalink

Main URL

See also

Coronavirus research

Success stories

Sensing module keeps watch beneath the waves

EU-funded researchers have designed a standard instrument module to monitor conditions in the deep sea. As part of a Europe-wide marine-sensing infrastructure, the modules will supply reliable long-term data on the state of our seas and oceans.

Permalink

Main URL

See also

Industry 5.0

Horizon magazine

Q&A: ‘We need to reduce the ‘embodied energy’ of buildings

Retrofitting Europe’s buildings for energy efficiency is not enough to slash the carbon footprint of the construction sector and cut emissions in time to meet the Paris climate agreement goals, according to Dr Catherine De Wolf, assistant professor of design and construction management at TU Delft in the Netherlands.

Permalink

Main URL

See also

Horizon magazine

The European Commission is committed to personal data protection. Any personal data is processed in line with the Regulation (EU) 2018/1725. Please read the privacy statement.

To unsubscribe or change your profile and selections please visit our web site.